This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miotto, P.
Right arrow Articles by Cirillo, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miotto, P.
Right arrow Articles by Cirillo, D. M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, July 2006, p. 2485-2491, Vol. 44, No. 7
0095-1137/06/$08.00+0     doi:10.1128/JCM.00083-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Use of Genotype MTBDR Assay for Molecular Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Clinical Strains Isolated in Italy

Paolo Miotto,1 Federica Piana,1 Valeria Penati,2 Filippo Canducci,3 Giovanni Battista Migliori,4 and Daniela Maria Cirillo1*

Emerging Bacterial Pathogens, San Raffaele Scientific Institute, Milan, Italy,1 Istituto Villa Marelli, Milan, Italy,2 Vita-Salute San Raffaele University and Microbiology and Virology Laboratory, Milan, Italy,3 WHO Collaborating Centre for Tuberculosis and Lung Disease, S. Maugeri Foundation, IRCCS, Tradate, Italy4

Received 13 January 2006/ Returned for modification 27 March 2006/ Accepted 1 May 2006

Mycobacterium tuberculosis is one of the leading causes of death worldwide, and multidrug-resistant tuberculosis (MDR-TB) is associated with a high case fatality rate. Rapid identification of resistant strains is crucial for the early administration of appropriate therapy, for prevention of development of further resistance, and to curtail the spread of MDR strains. The Genotype MTBDR (Hain Lifescience, Nehren, Germany) is a reverse hybridization line probe assay designed for the rapid detection of rpoB and katG gene mutations in clinical isolates. The ability of this technique to correctly identify resistant and MDR-TB strains was tested on 206 isolates from the Italian drug resistance surveillance system. This panel included the majority of MDR strains isolated in Italy in the past 3 years. The results of the test were compared to conventional drug susceptibility test performed on isolated strains and verified by sequencing the regions of interest of the bacterial genome. The rate of concordance between the results of the MTBDR and those obtained with "in vitro" sensitivity was 91.5% (130 of 142) for rifampin and 67.1% (116 of 173) for isoniazid. We also applied this test directly to a panel of 36 clinical specimens collected from patients with active TB. The MTBDR correctly identified the two cases of MDR-TB included in the panel. These results show that the MTBDR test is useful in the detection and management of tuberculosis when MDR disease is suspected.


* Corresponding author. Mailing address: Emerging Bacterial Pathogens, San Raffaele-Turro, via Stamira d'Ancona 20, 20127 Milan, Italy. Phone: 39 02 26437947. Fax: 39 02 26437989. E-mail: cirillo.daniela{at}hsr.it.


Journal of Clinical Microbiology, July 2006, p. 2485-2491, Vol. 44, No. 7
0095-1137/06/$08.00+0     doi:10.1128/JCM.00083-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Hofmann-Thiel, S., van Ingen, J., Feldmann, K., Turaev, L., Uzakova, G. T., Murmusaeva, G., van Soolingen, D., Hoffmann, H. (2009). Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan. Eur Respir J 33: 368-374 [Abstract] [Full Text]  
  • Evans, J., Stead, M. C., Nicol, M. P., Segal, H. (2009). Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa. J Antimicrob Chemother 63: 11-16 [Abstract] [Full Text]  
  • Ling, D. I., Zwerling, A. A., Pai, M. (2008). GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur Respir J 32: 1165-1174 [Abstract] [Full Text]  
  • Lacoma, A., Garcia-Sierra, N., Prat, C., Ruiz-Manzano, J., Haba, L., Roses, S., Maldonado, J., Dominguez, J. (2008). GenoType MTBDRplus Assay for Molecular Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Strains and Clinical Samples. J. Clin. Microbiol. 46: 3660-3667 [Abstract] [Full Text]  
  • Barnard, M., Albert, H., Coetzee, G., O'Brien, R., Bosman, M. E. (2008). Rapid Molecular Screening for Multidrug-Resistant Tuberculosis in a High-Volume Public Health Laboratory in South Africa. Am. J. Respir. Crit. Care Med. 177: 787-792 [Abstract] [Full Text]  
  • Miotto, P., Piana, F., Cirillo, D. M., Migliori, G. B. (2008). Genotype MTBDRplus: a Further Step toward Rapid Identification of Drug-Resistant Mycobacterium tuberculosis. J. Clin. Microbiol. 46: 393-394 [Full Text]  
  • Hillemann, D., Rusch-Gerdes, S., Richter, E. (2007). Evaluation of the GenoType MTBDRplus Assay for Rifampin and Isoniazid Susceptibility Testing of Mycobacterium tuberculosis Strains and Clinical Specimens. J. Clin. Microbiol. 45: 2635-2640 [Abstract] [Full Text]  
  • Afanas'ev, M. V., Ikryannikova, L. N., Il'ina, E. N., Sidorenko, S. V., Kuz'min, A. V., Larionova, E. E., Smirnova, T. G., Chernousova, L. N., Kamaev, E. Yu., Skorniakov, S. N., Kinsht, V. N., Cherednichenko, A. G., Govorun, V. M. (2007). Molecular characteristics of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates from the Russian Federation. J Antimicrob Chemother 59: 1057-1064 [Abstract] [Full Text]  
  • Somoskovi, A., Dormandy, J., Mitsani, D., Rivenburg, J., Salfinger, M. (2006). Use of Smear-Positive Samples To Assess the PCR-Based Genotype MTBDR Assay for Rapid, Direct Detection of the Mycobacterium tuberculosis Complex as Well as Its Resistance to Isoniazid and Rifampin. J. Clin. Microbiol. 44: 4459-4463 [Abstract] [Full Text]